Can Butylphthalide Soft Capsules Improve Paralysis?
Generally, Ligustrazine Soft Capsules can improve paralysis symptoms when used for central paralysis caused by stroke or brain injury. However, for patients with severe paralysis, long disease duration, or individual physical conditions and complications that impose limitations, the therapeutic effects may be relatively limited or have usage restrictions. If concerned, it is recommended to seek medical advice in advance. Detailed analysis is as follows:
Ligustrazine Soft Capsules have multiple functions, including nourishing nerves, repairing nerves, and improving cerebral vascular circulation. This medication promotes the repair and regeneration of damaged nerve cells and accelerates the recovery process of nerve function. It demonstrates certain therapeutic effects on central paralysis caused by stroke or brain injury, such as hemiplegia and sensory impairment of one side of the body. Especially for paralysis symptoms caused by acute ischemic stroke, Ligustrazine Soft Capsules can improve patients' motor functions and activities of daily living.
However, for patients with severe paralysis or long-standing disease duration, the therapeutic effect of Ligustrazine Soft Capsules may be relatively limited. Moreover, if patients suffer from severe hepatic or renal insufficiency, have an allergic constitution, or are allergic to the components of Ligustrazine, the use of Ligustrazine Soft Capsules may cause adverse reactions or exacerbate the existing condition. If paralysis is caused by other factors, such as spinal cord injury or neurodegenerative diseases, the therapeutic effect of Ligustrazine Soft Capsules may also be unsatisfactory.
Patients should maintain good living habits and a healthy, scientifically balanced diet in their daily life, actively adjusting their physical condition, in order to enhance treatment effectiveness when managing diseases.